Bone mineral density increased 4.8% in 12 months with MSDK

Bone mineral density increased 4.8% in 12 months with MSDK

Bone mineral density increased 4.8% in 12 months with MSDK

This one-year double blind randomized control trial assessed the effects of nightly melatonin, strontium (citrate), vitamin D3 and vitamin K2 (MK7; MSDK) on bone mineral density (BMD) and quality of life (QOL) in postmenopausal osteopenic women (ages 49-75). Compared to placebo, MSDK treatment increased BMD in lumbar spine (4.3%) and left femoral neck (2.2%)

Maria S, Swanson MH, Enderby LT, et al. Melatonin-micronutrients Osteopenia Treatment Study (MOTS): a translational study assessing melatonin, strontium (citrate), vitamin D3 and vitamin K2 (MK7) on bone density, bone marker turnover and health related quality of life in postmenopausal osteopenic women following a one-year double-blind RCT and on osteoblast-osteoclast co-cultures. Aging (Albany NY). 2017;9(1):256-285.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310667/

Advertisements


Categories: Uncategorized

Tags: , , , , , , , , , , , , ,

1 reply

  1. Strontium citrate?? You must be crazy to start prescribing strontium in this way. Strontium is these days under the microscope for being a cardiac poison – it redily replaces potassium and causes arrhythmias, atrial fibrilation included. Keep away from it, especiallialy the ranalate version of it.

    Like

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: